Biocon Gains After Arm Enters Strategic Alliance With Serum Institute

Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.

from NDTV Profit - Latest https://ift.tt/3hZqctF
Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.

Comments

Popular posts from this blog

RBI Vs Government: Finance Ministry To Shortly Issue A Statement

भारत-चीन की लड़ाई पहुंची बंदरगाहों पर! चीनी समान की हो रही है बारीकी से जांच